Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum
Anticancer Research · 2025
DOI: 10.21873/anticanres.17503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Takeshi Fujisawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Radiosurgery.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
- Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan; hhojo@east.ncc.go.jp.
- Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
- Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Zitieren
APA
Fujisawa, T., Hojo, H., Nakamura, M., Makita, K., Hirata, H., Oyoshi, H., Tomizawa, K., Zhou, Y., Fukushi, K., Ikeda, M., & Zenda, S. (2025). Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum. Anticancer Research. https://doi.org/10.21873/anticanres.17503
Vancouver
Fujisawa T, Hojo H, Nakamura M, Makita K, Hirata H, Oyoshi H, et al. Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum. Anticancer Research. 2025. doi:10.21873/anticanres.17503
BibTeX
@article{Fujisawa2025,
author = {Fujisawa, Takeshi and Hojo, Hidehiro and Nakamura, Masaki and Makita, Kenji and Hirata, Hidenari and Oyoshi, Hidekazu and Tomizawa, Kento and Zhou, Yuzheng and Fukushi, Keiko and Ikeda, Masafumi and Zenda, Sadamoto},
title = {Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17503}
}
EUVIMED